We buy the dip at our peril and yet buying when others are...

We buy the dip at our peril and yet buying when others are selling and fearful is the right strategy. BluGlass is well funded with great opportunities to further expand and develop our product offerings. Additional projects from CLAWS can still materialise in the second quarter 2024 and beyond so there is the potential to secure more funding.

Everything we expend on approved R&D gets an attractive 50% rebate from the ATO next financial year.

It won’t be long and the current sellers will be drowning in regret with the fence sitters who froze when they should have bought.

I have a sizeable position here now and look forward to the annual report and a significantly higher valuation. We need more orders and improved performance and more validation success. Time will tell.